Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121851 | 12612185 | 1 | I | 20160722 | 20160801 | 20160801 | EXP | PHHY2016JP102499 | SANDOZ | HEIANNA J, MUTO O, MIYAUCHI T, ENDO W, TOGASHI A, AZAMA K.. SUCCESSFUL TREATMENT CONTINUATION WITH A SINGLE MILD PARTIAL SPLENIC EMBOLIZATION FOR THROMBOCYTOPENIA CAUSED BY OXALIPLATIN-BASED CHEMOTHERAPY FOR ADVANCED COLON CANCER. INDIAN JOURNAL OF GASTROENTEROLOGY. 2016;35(3):245-7 | 28.00 | YR | F | Y | 0.00000 | 20160801 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126121851 | 12612185 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | Y | 78812 | ||||||||||
| 126121851 | 12612185 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Y | 78812 | |||||||||||
| 126121851 | 12612185 | 3 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | 0 | |||||||||||
| 126121851 | 12612185 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | 0 | ||||||||||||
| 126121851 | 12612185 | 5 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 126121851 | 12612185 | 6 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | 0 | ||||||||||||
| 126121851 | 12612185 | 7 | SS | 5 FLUORO URACIL | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126121851 | 12612185 | 8 | SS | 5 FLUORO URACIL | FLUOROURACIL | 1 | 0 | ||||||||||||
| 126121851 | 12612185 | 9 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | 0 | |||||||||||
| 126121851 | 12612185 | 10 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | 0 | ||||||||||||
| 126121851 | 12612185 | 11 | SS | PANITUMUMAB | PANITUMUMAB | 1 | Unknown | 0 | |||||||||||
| 126121851 | 12612185 | 12 | SS | PANITUMUMAB | PANITUMUMAB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126121851 | 12612185 | 1 | Colon cancer |
| 126121851 | 12612185 | 2 | Metastases to liver |
| 126121851 | 12612185 | 3 | Colon cancer |
| 126121851 | 12612185 | 4 | Metastases to liver |
| 126121851 | 12612185 | 5 | Colon cancer |
| 126121851 | 12612185 | 6 | Metastases to liver |
| 126121851 | 12612185 | 7 | Colon cancer |
| 126121851 | 12612185 | 8 | Metastases to liver |
| 126121851 | 12612185 | 9 | Colon cancer |
| 126121851 | 12612185 | 10 | Metastases to liver |
| 126121851 | 12612185 | 11 | Colon cancer |
| 126121851 | 12612185 | 12 | Metastases to liver |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126121851 | 12612185 | OT |
| 126121851 | 12612185 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126121851 | 12612185 | Disease progression | |
| 126121851 | 12612185 | Hepatic failure | |
| 126121851 | 12612185 | Metastases to liver | |
| 126121851 | 12612185 | Portal hypertension | |
| 126121851 | 12612185 | Splenomegaly | |
| 126121851 | 12612185 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |